Susumu Nakagawa

This inventor holds 38 USPTO granted patents, primarily in Cephalosporin Derivatives. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1987-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susumu Nakagawa. Retrieved from https://idiyas.com/inventor/susumu-nakagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38

% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 134(Granted Patents)

Location History:

Aichi, JP (1992)
Okazaki, JP (1987 - 1995)
Tsukuba, JP (1995 - 1998)
Nukata-gun, JP (2001)

Company Filing History:

38 out of 237

Banyu Pharmaceutical Co. Ltd

patents

Years Active: 1987-2001

Loading Chart...

Areas of Expertise:

Cephalosporin Derivatives

Carbapenem Derivatives

Aminoalkylpyrrolidinylthiocarbapenem

Enyne Derivatives

Piperidylthiocarbapenem

Cyclic Amidinylthiocarbapenem

Isoindoline Derivatives

Antibacterial Agents

Crystalline Compounds

3-Isoquinoliniomethyl

2-Carbon-Substituted

Intermediates

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6251891 - Carbapenem derivatives (2001-06-26),

2. 5707987 - Carbapenem derivatives (1998-01-13),

3. 5550121 - Aminoalkylpyrrolidinylthiocarbapenem derivatives (1996-08-27),

4. 5449672 - Alkylaminoalkylpyrrolidinylthiocarbapenem derivatives (1995-09-12),

5. 5440049 - Process for producing enyne derivatives (1995-08-08),

6. 5438054 - 2-(substituted pyrrolidinylthio) carbapenem derivatives (1995-08-01),

7. 5436354 - Intermediates for producing enyne derivatives (1995-07-25),

8. 5407930 - Cephalosporin derivatives (1995-04-18),

9. 5403835 - Cephalosporin derivatives (1995-04-04),

10. 5374720 - 2-(substituted pyrrolidinylthio)carbapenem derivatives (1994-12-20),

11. 5373002 - 2-(substituted pyrrolidinylthio) carbapenem derivatives (1994-12-13),

12. 5359091 - Intermediates for producing enyne derivatives (1994-10-25),

13. 5296612 - Process for producing enyne derivatives (1994-03-22),

14. 5258509 - Process for producing 2-carbon-substituted carbapenem derivatives (1993-11-02),

15. 5231183 - Process for producing enyne derivatives (1993-07-27),

Title: The Innovative Contributions of Susumu Nakagawa in Pharmaceuticals

Introduction: Susumu Nakagawa, a prominent inventor based in Okazaki, Japan, is well-known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 38 patents, Nakagawa has made strides in developing essential compounds that aid in combating various medical conditions.

Latest Patents: Among his most recent innovations are the carbapenem derivatives, which are represented by a general formula formulated to enhance the efficacy of antibiotic treatments. This innovative work demonstrates Nakagawa's commitment to addressing pressing health challenges through pharmaceutical innovation.

Career Highlights: Throughout his career, Nakagawa has been associated with Banyu Pharmaceutical Co. Ltd., where he has played a crucial role in drug development. His extensive patent portfolio reflects his continued dedication to advancing pharmaceutical technology and providing solutions that improve patient outcomes.

Collaborations: Nakagawa has collaborated with talented professionals such as Ryosuke Ushijima and Koji Yamada, contributing to the innovation landscape within the pharmaceutical industry. These partnerships have facilitated the sharing of knowledge and expertise, further enhancing the development of new medications.

Conclusion: Susumu Nakagawa's innovative work in the field of pharmaceuticals and his extensive patent portfolio underscore his importance as an inventor. His contributions, especially in the realm of carbapenem derivatives, illustrate the profound impact that dedicated inventors can have on health care and the pharmaceutical industry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]